Rohr

Biocomposites to present latest STIMULAN® data at the European Bone and Joint Infection Society Annual Meeting

Retrieved on: 
Thursday, September 1, 2022

The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.

Key Points: 
  • The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.
  • Michael Harris, Chief Executive Officer of Biocomposites, added: "Biocomposites is pleased to be leading the field in orthopaedics by once again presenting new STIMULAN data at this important annual meeting.
  • EBJIS holds an annual meeting which brings together experts, practitioners and companies involved in the treatment of bone and joint infections.
  • This year, the theme of the meeting will be 'optimising diagnosis and management of bone and joint infections'.

Biocomposites to present latest STIMULAN® data at the European Bone and Joint Infection Society Annual Meeting

Retrieved on: 
Thursday, September 1, 2022

The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.

Key Points: 
  • The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.
  • Michael Harris, Chief Executive Officer of Biocomposites, added: "Biocomposites is pleased to be leading the field in orthopaedics by once again presenting new STIMULAN data at this important annual meeting.
  • EBJIS holds an annual meeting which brings together experts, practitioners and companies involved in the treatment of bone and joint infections.
  • This year, the theme of the meeting will be 'optimising diagnosis and management of bone and joint infections'.

Luminary Medical Group Welcomes Barbara Rohr, APRN-BC

Retrieved on: 
Tuesday, June 1, 2021

BRADENTON, Fla., June 1, 2021 /PRNewswire-PRWeb/ --Luminary Medical Group is happy to announce the addition of highly specialized Nurse Practitioner, Barbara Rohr, APRN-BC, to its rapidly growing stable of multi-specialty providers.

Key Points: 
  • BRADENTON, Fla., June 1, 2021 /PRNewswire-PRWeb/ --Luminary Medical Group is happy to announce the addition of highly specialized Nurse Practitioner, Barbara Rohr, APRN-BC, to its rapidly growing stable of multi-specialty providers.
  • With the exciting addition of Barbara Rohr, Luminary Medical Group is continuing to expand their extensive list of quality services in greater Sarasota and Manatee counties.
  • Luminary Medical Group was founded in 2019, by Cary L. Dunn, M.D.
  • For more information regarding Luminary Medical Group and Luminary Provider Barbara Rohr, APRN-BC, visit LuminaryMedicalGroup.com

Chief Executive Officer Lori Ryerkerk Named Chairman

Retrieved on: 
Thursday, April 16, 2020

Lori Ryerkerk, President and Chief Executive Officer, has been elected by the Board to succeed Rohr as Chairman following the companys Annual Meeting today.

Key Points: 
  • Lori Ryerkerk, President and Chief Executive Officer, has been elected by the Board to succeed Rohr as Chairman following the companys Annual Meeting today.
  • Rohr was appointed Executive Chairman of Celanese in May 2019, following his tenure as Chairman, President and CEO since April 2012.
  • Having completed a successful onboarding and transition of all leadership responsibilities to Ryerkerk, Rohr felt now was the right time to retire.
  • Ryerkerk said, I am honored to have been chosen to succeed Mark as the Chairman of the Board of this extraordinary company.

The PNC Financial Services Group Announces First Quarter 2020 Earnings Conference Call And Annual Shareholders Meeting Details

Retrieved on: 
Monday, March 9, 2020

PITTSBURGH, March 9, 2020 /PRNewswire/ --The PNC Financial Services Group, Inc. (NYSE: PNC) expects to issue financial results for the first quarter of 2020 Wednesday, April 15, as previously announced, at approximately 6:45 a.m. (ET).

Key Points: 
  • PITTSBURGH, March 9, 2020 /PRNewswire/ --The PNC Financial Services Group, Inc. (NYSE: PNC) expects to issue financial results for the first quarter of 2020 Wednesday, April 15, as previously announced, at approximately 6:45 a.m. (ET).
  • Separately, PNC will hold its Annual Meeting of Shareholders Tuesday, April 28, 2020.
  • Conference call replay will be available for one week at (800) 633-8284 and (402) 977-9140, Conference ID 21952111.
  • 2020 Annual Meeting of Shareholders: Tuesday, April 28, at 11 a.m. (ET)
    Meeting location:The PNC Financial Services Group, Inc., The Tower at PNC Plaza James E. Rohr Auditorium, 300 Fifth Avenue, Pittsburgh, Pennsylvania 15222.

The PNC Financial Services Group Announces First Quarter 2019 Earnings Conference Call Details

Retrieved on: 
Tuesday, March 5, 2019

PITTSBURGH, March 5, 2019 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) expects to issue financial results for the first quarter of 2019 Friday, April 12, as previously announced, at approximately 6:45 a.m. (ET).

Key Points: 
  • PITTSBURGH, March 5, 2019 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) expects to issue financial results for the first quarter of 2019 Friday, April 12, as previously announced, at approximately 6:45 a.m. (ET).
  • Separately, PNC will hold its Annual Meeting of Shareholders Tuesday, April 23, 2019.
  • Event details are as follows:
    First Quarter 2019 Earnings Investor Conference Call: Friday, April 12, at 9:30 a.m. (ET)
    Accessible at www.pnc.com/investorevents will be a link to the live audio webcast, presentation slides, earnings release and supplementary financial information; a webcast replay will be available for 30 days.
  • 2019 Annual Meeting of Shareholders: Tuesday, April 23, at 11 a.m. (ET)
    Meeting location:The PNC Financial Services Group, Inc., The Tower at PNC Plaza James E. Rohr Auditorium, 300 Fifth Avenue, Pittsburgh, Pennsylvania 15222.